By writer to www.globenewswire.com
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) — The “Organ Preservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s providing.
The worldwide organ preservation market grew at a CAGR of 6.5% throughout 2014-2019. Organ preservation refers back to the strategy of preserving wholesome organs harvested from the physique of donors. The method entails the removing of organs from the donor’s physique, storing it for transportation after which transplanting it into the receiver’s physique with out vital injury. It makes use of varied strategies, reminiscent of hypothermic machine perfusion, static chilly storage (SCS) and normothermic machine perfusion (NMP), to keep up the temperature and oxygen ranges of kidneys, liver, lung, coronary heart and different organs. The preservation strategies and options used are important for donor organ high quality, which immediately influences the morbidity and survival charges of a affected person after transplantation.
The growing prevalence of persistent illnesses, together with the rising geriatric inhabitants throughout the globe, are among the many key elements driving the expansion of the market. Owing to the frequent occurrences of organ failures as a result of diabetes, cardiovascular issues (CVDs), weight problems, and different such extreme medical situations, there may be an growing want for organ preservation procedures. The appearance of modern and superior strategies, reminiscent of NMP, for organ preservation, is performing as a growth-inducing issue. Such strategies help in reducing the likelihood of reperfusion harm throughout transplantation and displays improved ends in chilly storage for medical and experimental research.
Furthermore, an growing variety of authorities and non-government insurance policies and initiatives to advertise organ donation are impacting the market progress positively. The rising variety of people volunteering to donate their organs for transplantation and analysis functions are additionally driving the market additional. Different elements, together with enhanced analysis and improvement (R&D) and vital developments within the organ preservation infrastructure, are additionally projected to contribute to the market progress considerably. Wanting ahead, the writer expects the market to exhibit reasonable progress in the course of the subsequent 5 years.
Breakup by Preservation Answer:
- UW Answer
- Custodiol HTK
- Perfadex
- Others
Breakup by Organ Donation Kind:
- Residing Organ Donation
- Deceased Organ Donation
Breakup by Approach:
- Static Chilly Storage Approach
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
Breakup by Organ Kind:
- Kidney
- Liver
- Lung
- Coronary heart
- Others
Breakup by Finish-Consumer:
- Hospitals and Clinics
- Organ Banks
- Others
Aggressive Panorama:
The report has additionally analysed the aggressive panorama of the market with among the key gamers being 21st Century Medication, Biolife Options, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Kohler Chemie GmbH, Important Prescription drugs., Lifeline Scientific, OrganOx, Paragonix Applied sciences, TransMedics, Waters Medical Techniques, Xvivo Perfusion, and so forth.
Key Questions Answered on this Report:
- How has the worldwide organ preservation market carried out to this point and the way will it carry out within the coming years?
- What are the important thing regional markets?
- What’s the breakup of the market primarily based on the preservation resolution?
- What’s the breakup of the market primarily based on the organ donation kind?
- What’s the breakup of the market primarily based on the approach?
- What’s the breakup of the market primarily based on the organ kind?
- What’s the breakup of the market primarily based on the end-user?
- What are the varied levels within the worth chain of the business?
- What are the important thing driving elements and challenges within the business?
- What’s the construction of the worldwide organ preservation market and who’re the important thing gamers?
- What’s the diploma of competitors within the business?
Key Subjects Coated:
1 Preface
2 Scope and Methodology
2.1 Aims of the Examine
2.2 Stakeholders
2.Three Knowledge Sources
2.3.1 Major Sources
2.3.2 Secondary Sources
2.Four Market Estimation
2.4.1 Backside-Up Strategy
2.4.2 Prime-Down Strategy
2.5 Forecasting Methodology
Three Government Abstract
Four Introduction
4.1 Overview
4.2 Key Business Traits
5 World Organ Preservation Market
5.1 Market Overview
5.2 Market Efficiency
5.Three Market Forecast
6 Market Breakup by Preservation Answer
6.1 UW Answer UW Answer
6.1.1 Market Traits
6.1.2 Market Forecast
6.2 Custodiol HTK
6.2.1 Market Traits
6.2.2 Market Forecast
6.Three Perfadex
6.3.1 Market Traits
6.3.2 Market Forecast
6.Four Others
6.4.1 Market Traits
6.4.2 Market Forecast
7 Market Breakup by Organ Donation Kind
7.1 Residing Organ Donation
7.1.1 Market Traits
7.1.2 Market Forecast
7.2 Deceased Organ Donation
7.2.1 Market Traits
7.2.2 Market Forecast
Eight Market Breakup by Approach
8.1 Static Chilly Storage Approach
8.1.1 Market Traits
8.1.2 Market Forecast
8.2 Hypothermic Machine Perfusion
8.2.1 Market Traits
8.2.2 Market Forecast
8.Three Normothermic Machine Perfusion
8.3.1 Market Traits
8.3.2 Market Forecast
8.Four Others
8.4.1 Market Traits
8.4.2 Market Forecast
9 Market Breakup by Organ Kind
9.1 Kidney
9.1.1 Market Traits
9.1.2 Market Forecast
9.2 Liver
9.2.1 Market Traits
9.2.2 Market Forecast
9.Three Lung
9.3.1 Market Traits
9.3.2 Market Forecast
9.Four Coronary heart
9.4.1 Market Traits
9.4.2 Market Forecast
9.5 Different Organs
9.5.1 Market Traits
9.5.2 Market Forecast
10 Market Breakup by Finish-Consumer
10.1 Hospitals and Clinics
10.1.1 Market Traits
10.1.2 Market Forecast
10.2 Organ Banks
10.2.1 Market Traits
10.2.2 Market Forecast
10.Three Others
10.3.1 Market Traits
10.3.2 Market Forecast
11 Market Breakup by Area
11.1 North America
11.1.1 United States
11.1.1.1 Market Traits
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Traits
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Traits
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Traits
11.2.2.2 Market Forecast
11.2.Three India
11.2.3.1 Market Traits
11.2.3.2 Market Forecast
11.2.Four South Korea
11.2.4.1 Market Traits
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Traits
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Traits
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Traits
11.2.7.2 Market Forecast
11.Three Europe
11.3.1 Germany
11.3.1.1 Market Traits
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Traits
11.3.2.2 Market Forecast
11.3.Three United Kingdom
11.3.3.1 Market Traits
11.3.3.2 Market Forecast
11.3.Four Italy
11.3.4.1 Market Traits
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Traits
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Traits
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Traits
11.3.7.2 Market Forecast
11.Four Latin America
11.4.1 Brazil
11.4.1.1 Market Traits
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Traits
11.4.2.2 Market Forecast
11.4.Three Others
11.4.3.1 Market Traits
11.4.3.2 Market Forecast
11.5 Center East and Africa
11.5.1 Market Traits
11.5.2 Market Breakup by Nation
11.5.Three Market Forecast
12 SWOT Evaluation
12.1 Overview
12.2 Strengths
12.Three Weaknesses
12.Four Alternatives
12.5 Threats
13 Worth Chain Evaluation
14 Porters 5 Forces Evaluation
14.1 Overview
14.2 Bargaining Energy of Consumers
14.Three Bargaining Energy of Suppliers
14.Four Diploma of Competitors
14.5 Risk of New Entrants
14.6 Risk of Substitutes
15 Worth Indicators
16 Aggressive Panorama
16.1 Market Construction
16.2 Key Gamers
16.Three Profiles of Key Gamers
16.3.1 21st Century Medication Inc.
16.3.1.1 Firm Overview
16.3.1.2 Product Portfolio
16.3.2 Biolife Options Inc.
16.3.2.1 Firm Overview
16.3.2.2 Product Portfolio
16.3.2.Three Financials
16.3.Three Bridge to Life Ltd.
16.3.3.1 Firm Overview
16.3.3.2 Product Portfolio
16.3.Four Bristol-Myers
16.3.4.1 Firm Overview
16.3.4.2 Product Portfolio
16.3.4.Three Financials
16.3.4.Four SWOT Evaluation
16.3.5 Dr. Franz Kohler Chemie GmbH
16.3.5.1 Firm Overview
16.3.5.2 Product Portfolio
16.3.5.Three Financials
16.3.6 Important Prescription drugs LLC
16.3.6.1 Firm Overview
16.3.6.2 Product Portfolio
16.3.7 Lifeline Scientific Inc.
16.3.7.1 Firm Overview
16.3.7.2 Product Portfolio
16.3.Eight OrganOx Ltd.
16.3.8.1 Firm Overview
16.3.8.2 Product Portfolio
16.3.8.Three Financials
16.3.9 Paragonix Applied sciences Inc.
16.3.9.1 Firm Overview
16.3.9.2 Product Portfolio
16.3.10 Transmedics, Inc.
16.3.10.1 Firm Overview
16.3.10.2 Product Portfolio
16.3.11 Waters Medical Techniques LLC
16.3.11.1 Firm Overview
16.3.11.2 Product Portfolio
16.3.12 Xvivo Perfusion
16.3.12.1 Firm Overview
16.3.12.2 Product Portfolio
16.3.12.Three Financials
For extra details about this report go to https://www.researchandmarkets.com/r/p0fcqx
Analysis and Markets additionally affords Custom Research providers offering centered, complete and tailor-made analysis.
CONTACT: ResearchAndMarkets.com Laura Wooden, Senior Press Supervisor press@researchandmarkets.com For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900